FDA May Speed Drug Ad Review For Fee
The U.S. Food and Drug Administration has reached a tentative agreement with pharmaceutical companies that would allow companies to pay the FDA fees to inspect their television ads in exchange for...To view the full article, register now.
Already a subscriber? Click here to view full article